Patent Yard Sign in
Canadian application, no grantCanada

Gene therapy delivery system for targeting to endothelia

CA 2257300 A1 · Owner: Illum, Lisbeth · Inventors: Illum, Lisbeth

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A composition comprising biodegradable microspheres that act as carriers for the delivery of DNA to the endothelial cells of a vascular bed wherein the , microspheres carry a net negative charge and to which is adsorbed positively charged particles of a smaller size, wherein such positively charged particles comprise a conjugate of DNA and a cationic compacting agent.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 10, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 10, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 10, 1997
GrantedNo grant recorded
Term endedJuly 10, 2017
Patent numberCA 2257300 A1
Classification (IPC)A61K48/00 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedJuly 10, 1997Term endedJuly 10, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.